Cambridge
From The Long Sepsis, an encyclopedia of a world that didn't happen
Cambridge, a city in the East of England and home to the University of Cambridge, emerged in the latter twentieth century as one of Europe's primary research sites for serum therapy development and the statistical methods required to evaluate it. The city's importance to bacterial medicine in the Long Sepsis was built neither on wealth nor established medical dominance, but on the convergence of three circumstances: a strong mathematics tradition suitable to the novel demands of survival analysis, physical isolation that permitted the containment protocols demanded by asepsis maximalism, and the presence of the Infectious Disease Research Centre, established in 1968 as an independent institute devoted entirely to serum-based passive immunization.
The Infectious Disease Research Centre was founded with funding from the Medical Research Council and private charitable grants, occupying a purpose-built facility outside the city centre designed on clean ward principles. Its first director was Dorothy Umezaki, who had spent the 1960s at the Pasteur Institute attempting to move serum therapy beyond the empirical small-scale trials that characterized the field. At Cambridge, she assembled a team that included statisticians trained in industrial reliability methods, microbiologists trained in bacterial genetics, and clinicians from teaching hospitals across southern England. The institute's early focus was on endocarditis and meningitis, both rapidly fatal conditions for which antitoxin treatment showed promise but inconsistent results.
The Centre's crucial contribution was methodological rather than biochemical. Working with the statistician Paul Kaplan and others, researchers adapted the Kaplan-Meier survival estimator—originally developed for industrial failure analysis—to measure serum therapy efficacy in the absence of rapid cure. This was conceptually novel: earlier medical statistics had assumed either recovery or death within a defined time window. Serum therapy offered neither. Patients survived or died slowly, over weeks or months, with incomplete responses. The Kaplan-Meier method made it possible to measure and compare partial survival, making visible what had been statistically invisible.
By the mid-1970s, Cambridge had become the methodological centre for serum therapy trials across Europe. The Centre coordinated the International Serum Registry, established in 1975 as a federated database of outcomes and donor serum stocks. Cambridge researchers developed standardized protocols for patient follow-up, loss-to-follow-up correction, and the comparison of serum batches across different donor animals and different national production systems. Much of this work entered print as technical manuals and statistical guidance rather than primary research papers, making the Centre's influence difficult to measure through citation counts alone.
The work proceeded in constant tension with the Geneva Sanitary Bureau, the international coordination body responsible for serum therapy standards. Cambridge researchers pushed for randomized comparisons between serum lots and for quantified measurement of batch potency. The Geneva Bureau, representing multiple national health systems with different manufacturing capabilities and donor herds, favoured standardized protocols that did not require comparative trials. This disagreement between statistical rigour and operational feasibility shaped serum therapy policy through the 1980s; the Bureau's position generally prevailed, though Cambridge's methodological framework became the basis for rare large-scale trials when comparative claims needed to be settled.
References
- 1.The Halloway Papers: Cambridge Correspondence 1971-1979]], Dorothy Umezaki and John Halloway, Archives of the Institute for the History of Bacteriology, Berlin, 1998, folio 45-87
- 2.Kaplan-Meier Methods in Infection Trials: Application and Critique]], Paul Kaplan and Margaret Chen, Journal of Clinical Statistics, 1982, vol. 14, no. 3, pp. 234-251
- 3.The Infectious Disease Research Centre: Institutional History and Scientific Output 1968-1995]], Cambridge University Press, 1996, pp. 78-156
- 4.Statistical Methods in Medical Research]], Richard Reinhardt, Archives of Bacteriology and Public Health, 1985, vol. 22, no. 2, pp. 112-131
- 5.Cambridge and the International Serum Registry: Trial Coordination in the Long Sepsis]], Helen Stavropoulou, History of Science, 2003, vol. 41, no. 2, pp. 189-218